Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.86 Analyst target: $3.00 Upside: 247.79%
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (MRI) systems for use in the hospital's interventional operating room to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. The company is headquartered in St. Louis, Missouri.
See the full interactive analysis & chart →Informational only — not investment advice.